INTRODUCTION {#S1}
============

Generalised anxiety disorders are estimated to affect 44 out of 1000 adults in Great Britain. Evidence suggests that certain population groups are at greater risk, with deprived communities experiencing higher prevalence of treated anxiety.[@B1]-[@B3] Age and gender also predict higher prevalence with sharply increasing minor tranquiliser[†](#fn1){ref-type="fn"} prescribing rates in the elderly, particularly amongst older females.[@B1],[@B4] Previous studies have indicated that extent of local deprivation and population socioeconomic characteristics may influence general practice minor tranquiliser prescribing and prescribing for other conditions, as well as affecting appropriate service provision. However population factors do not consistently predict higher prescribing and there is evidence of lower prescribing rates across a range of health conditions in some deprived and ethnically diverse areas.[@B5]-[@B8]

Variable prescribing rates for heart disease, relative to local need, have been associated with aspects of primary care quality and differences in health care equity.[@B9],[@B10] In 2003/4, as part of a range of health inequalities monitoring exercises, the English Commission for Health Improvement (CHI) published data from a national performance assessment.[@B11] The exercise included a prescribing indicator comparing rates for drugs acting on benzodiazepine receptors (WHO ATC N05C; BNF 4.1.1) amongst the 302 Primary Care Organisations (PCOs) which are the main local providers of primary health care services. The survey revealed extensive disparities amongst PCOs (mean=8.78 ADQs per STAR-PU; range=3.90--15.52; SD=2.76) ([@B10]). Using the CHI performance thresholds, benzodiazepine prescribing rates for 31 PCOs (10%) were classified as inappropriately high and performance considered "significantly below average". Of this group, 22 (71%) were included in the 88 "spearhead" PCOs, identified by the Department of Health as those areas experiencing the greatest health deprivation, characterised by rates of high material deprivation, mortality and numbers of life years lost.[@B12] Conversely, out of the 12 lowest benzodiazepine prescribing PCOs, five (42%) were "spearhead" PCOs, all located within the London area.

Several small scale studies exploring reasons for variations in minor tranquiliser prescribing by general practices have been performed in England. These studies outlined below, have examined potential associations between prescribing rates and general practice characteristics and local population demographics. Significant differences in anxiolytics, hypnotics and antidepressants prescribing rates were found within a group of 61 general practices.[@B13] The strength of associations with prescribing and practice or population characteristics were limited in this study, with the findings only suggesting that temporary residential status and females aged 65 years or over predicting higher prescribing rates.[@B13] Other studies have established stronger relationships with practice characteristics. Benzodiazepine prescribing in a sample of 350 general practices was lower in general practices providing general practitioner (GP) training, that were multiple partner practices or located in more affluent areas.[@B14] A study of 78 general practices found significant correlations between local extent of morbidity and antidepressant prescribing.[@B15] The ratio of numbers of general practitioners per head of population and proportion of the population not having English as a first language were found to be predictors of variation for anxiety and depression in 39 relatively deprived neighbourhoods. [@B16] Illustrative of the difficulties in interpreting predictors of variation, an east London based study found that higher prevalence of Asian ethnicity in the local community accounted for significantly lower rates of anxiolytic prescribing. The authors commented on the uncertainty of whether this was caused by lower disease prevalence, general practitioner prescribing behaviour or difficulties with screening for anxiety. The divergence of predictors gleaned from these studies could stem from the geographically diverse settings of the research and their particular demographic and socioeconomic profiles.

The aim of this study is to explore the relationship between minor tranquiliser prescribing rates and socioeconomic, demographic and general practice characteristics using data which includes all general practices in England. The study uses small area population data, linked to each general practice, from a variety of national datasets.

METHODS {#S2}
=======

Prescribing data {#S3}
----------------

Weighted volumes of minor tranquilisers (WHO ATC classifications N05B, N05C / BNF Chapter 4.1) prescribed were used as the general practice level outcome measure.[@B17] In 2004, anxiolytics constituted 62% of all dispensed minor tranquilisers, while hypnotics accounted for 38% and barbiturates 0.2%.[@B18] Prescribing volume data for the period April 2004 to March 2005, were provided by the Prescription Pricing Authority, derived from the national Prescribing Analysis and Cost (PACT) database. Specific Therapeutic group Age-sex Related Prescribing Units (STAR-PU) weightings were applied to compare prescribing volumes for individual general practice. This measure accounts for the age, gender and temporary residence profile of each general practice's patient register, providing a numerical weighted compensation for differences in practice population age and sex proportions.[@B19] Prescription volumes were measured using average daily quantities (ADQ) which are analytical units for comparing prescribing activity amongst the major drug groups in England.[@B20] ADQ per STAR-PU are extensively used in England by administrative and governing health organisations to monitor appropriate general practice prescribing and comparative costs, within therapeutic groups. ADQs were adopted in recognition of the differences in prescribing patterns by English general practices compared to the WHO classification of Daily Defined Doses (DDDs) which are based on general international prescribing habits, consequently not accurately reflecting activity in England.

Population characteristics {#S4}
--------------------------

A range of potential population-based explanatory variables, derived from several sources, was constructed to test the extent to which prescribing activity could be explained by these. Population characteristics were attributed to each general practice using the weighted local Index of Multiple Deprivation (IMD) and demographic features obtained from the Office of National Statistics 2001 Census.[@B21] Data were linked by practice postcode, using lower level super output areas (SOA) which are small area geographical units of approximately 1500 residents. SOAs allow measurement of local concentration, extent or weighted averages of population characteristics.

The IMD measure combines seven dimensions of deprivation: income deprivation; employment deprivation; health deprivation and disability; education, skills and training deprivation; barriers to housing and services; living environment deprivation; and crime and living environment. The indicator provides a neighbourhood deprivation score for the practice location as home address specific data for registered patients were not available nationally. The IMD has been used frequently as an indicator for tests of association between local deprivation and equity of primary care service provision.[@B22]-[@B24]

Potential determinants of population health status were obtained from the 2001 Office of National Statistics Census, aggregated to SOA level and linked to general practices, attributing local population estimates of:

ethnic originhousing tenurelimiting long-term illnesslone parent statusNational Statistics -- Socio-economic Classification (NS-SeC)

Previous research has shown association between ethnic composition of the population and broad patterns prescribing rates in primary care in England.[@B8] Housing tenure can be used as a socioeconomic marker of health status which may, in itself, contribute to improving or worsening health.[@B25] Households with limiting long-term illness, is a self-reported measure allowing investigation of differences in local health need.[@B26] Lone parents, 95% of whom were female, have been shown to experience significantly poorer health.[@B27] The NS-SeC uses employment occupation type or status as a method of classifying social position.[@B28],[@B29] There are eight classes: large employers and higher managerial and professional occupations; lower managerial and professional occupations; intermediate occupations; lower supervisory and technical occupations; semi-routine occupations; routine occupations; never worked and long-term unemployed.

General practice characteristics {#S5}
--------------------------------

Practice characteristics indicators were obtained from the 2005 General Medical Services Statistics, extracted from the National Primary Care Database.[@B30] Proportions of registered patients aged 75 or over on each practice patient register were used as a proxy measure for intensity of general practice workload, with older people accounting for a relatively large proportion of general practitioner consultations and prescribing.[@B31],[@B32] The data included general practice list size per full time equivalent general practitioner; single-handed GP status; training practice status; practice incentive and payment circumstance indicated by Personal Medical Services (PMS) status. Over a third (35.5%) of practices were contracted under the Personal Medical Services scheme in 2004. Training practices are accredited centres for training GP specialty registrars, medical students and returning career-break GPs.

Quality and Outcomes Framework (QOF) data relating to general practice disease prevalence were obtained from the NHS Information Centre for the period April 2004 to March 2005.[@B33] The QOF system, introduced through the 2004 General Medical Services (GMS) contract, provides financial incentives to achieve a series of clinical, organisational and patient experience activity targets. The clinical element covers management aspects of 11 chronic illnesses: coronary heart disease; mental health; stroke; hypertension; diabetes; chronic obstructive pulmonary disease; hyperthyroid; cancer; left ventricular dysfunction; asthma and epilepsy.

The QOF exercise includes maintenance of disease registers by practices, allowing calculation of practice level raw prevalence rates. Prevalence rates are calculated by dividing practice disease registers by numbers of patients on the practice patient list. Though open to some interpretation by GPs for inclusion on the register, mental health registers contain those people with severe or long- term mental health problems who have agreed to regular follow-up consultation.[@B34] A further QOF indicator, achievement of 10 minutes length of consultation, was also included as an indicator of practice management quality.

Statistical methods {#S6}
-------------------

A dataset was developed incorporating prescribing volumes, practice characteristics, QOF data and attributed population characteristics. Differences in extraction dates for the 2004 GMS and 2004-05 QOF datasets and data validation reduced the number of practices eligible for inclusion in the study from 8576 to 8291 (96.7%). The differences in numbers were caused by practices opening and closing over the intervening period or being excluded from the study due to recorded list sizes of fewer than 750 registered patients. Twelve further practices were excluded on the grounds that their prescribing rates were zero. The outcome variable in this study was the ADQ per 1,000 STAR-PUs of prescribed minor tranquillizers for each general practice.

Data analysis was performed using Stata (version 9.2). Many of the potential independent variables were highly co-linear and many were not linearly related to the outcome variable, due to very high skewness. Therefore, we used only a subset of the variables, selected so as to avoid co-linearity. These variables were then categorised ([Table 1](#T1){ref-type="table"}). Multiple regressions were performed to determine which variables were most strongly associated with the prescribing of minor tranquillisers. We used the logarithm of the prescribing rate, due to the highly skewed distribution of the actual prescribing rates: a not insignificant number of practices had very high prescribing volumes. As there was no wider reference population to which the data could be generalised, formal significance testing is highly contentious; as such, we concentrate on the general interpretation of the model parameters rather than statistical significance. In such a large dataset, all associations are likely to be significant in any case.

###### 

Distribution summary of variables used in the regression analysis

  ----------------------------------------------------------------------------------------------------------------------------------------------- ------------------- ----------------------------------- --------------------- -------------------
  Predictor group                                                                                                                                 Category            Median [†](#t1fn1){ref-type="fn"}   Interquartile range   Range
  Minor tranquiliser volume (average daily quantities (ADQs) per 1,000 specific therapeutic group age-sex weightings prescribing unit (STAR-PU)   na                  9887.2                              6794.2 - 14132.5      109.2 - 134133.5
  Proportion of patients from south Asian ethnic group A                                                                                          0%                  10470                               7386.3 - 14218.2      135.2 - 49051.5
  Proportion of patients from south Asian ethnic group B                                                                                          \>0 and \<=2%       10380.0                             7392.0 - 14565.5      234.3 - 71524.4
  Proportion of patients from south Asian ethnic group C                                                                                          \>2 and \<=10%      9428.6                              6313.7 - 13744.1      110.14 - 134133.5
  Proportion of patients from south Asian ethnic group D                                                                                          \>10%               8649.8                              5228.8 - 13428.2      109.2 - 114154.7
  Proportion of patients from black ethnic group A                                                                                                0%                  10746.9                             7712.6 - 14492.2      135.2 - 101664.5
  Proportion of patients from black ethnic group B                                                                                                \>0 and \<=2%       10409.7                             7367.3 - 14741.3      110.1 - 114154.7
  Proportion of patients from black ethnic group C                                                                                                \>2 and \<=10%      9005.6                              5951.4 - 13313.4      109.2 - 134133.5
  Proportion of patients from black ethnic group D                                                                                                \>10%               6525.7                              4075.6 - 9954.9       119.7 - 64681.8
  Unadjusted disease prevalence: mental health A                                                                                                  \<=0.5%             9552.0                              6602.2 - 13752.2      110.1 - 101644.5
  Unadjusted disease prevalence: mental health B                                                                                                  \> 0.5% and \<=1%   10023.6                             6767.1 - 141779       218.5 - 114154.7
  Unadjusted disease prevalence: mental health C                                                                                                  \>1%                10857.1                             7424.4 - 15936.3      109.2 - 134133.5
  Unadjusted disease prevalence: epilepsy A                                                                                                       \<=0.5%             8252.0                              5449.2 - 11968.1      109.2 - 114154.7
  Unadjusted disease prevalence: epilepsy B                                                                                                       \> 0.5% and \<=1%   10675.5                             7634.8 - 14857.5      234.3 - 134133.5
  Unadjusted disease prevalence: epilepsy C                                                                                                       \>1%                14605.8                             10240.1 - 21703.5     2800.0 - 62908.1
  Index of Multiple Deprivation A                                                                                                                 \<=10               8355.2                              6154.6 - 11037.0      110.1 - 61846.1
  Index of Multiple Deprivation B                                                                                                                 \>10 and \<=20      9203.2                              6738.6 - 12450.9      245.2 - 52785.6
  Index of Multiple Deprivation C                                                                                                                 \>20 and \<=40      10655.7                             70761.8 - 15026.5     109.2 - 134133.5
  Index of Multiple Deprivation D                                                                                                                 \>40                12454.6                             7632.6 - 17992.5      119.7 - 101664.5
  Mean general practice GP age A                                                                                                                  \<40                8993.14                             6104.6 - 13105.6      466.6 - 40843.2
  Mean general practice GP age B                                                                                                                  \>=40 and \<50      9565.4                              6897.3 - 13179.8      110.1 - 114154.7
  Mean general practice GP age C                                                                                                                  \>=50 and \<60      10687.5                             6983.5 - 15766.7      109.2 - 134133.5
  Mean general practice GP age D                                                                                                                  \>=60               10843.3                             6174.1 - 16772.0      135.2 - 92836.8
  Proportion of list aged 75 or over A                                                                                                            \<=5%               8007.2                              4876.6 - 13112.1      110.1 - 134133.5
  Proportion of list aged 75 or over B                                                                                                            \>5% and \<=10%     10200.2                             7196.5 - 14384.7      109.2 - 114154.7
  Proportion of list aged 75 or over C                                                                                                            \>10%               10947.3                             8100.1 - 14344.4      496.4 - 51281.4
  Single-handed practices                                                                                                                                             10663.7                             6213.0 - 16441.2      119.7 - 16441.2
  Group practices                                                                                                                                                     9715.4                              6932.5 - 13576.5      109.2 - 134133.5
  Training practices                                                                                                                                                  9019.8                              6586.1 - 12236.1      109.2 - 45207.2
  Non-training practices                                                                                                                                              10317.1                             6903 - 14917.5        110.1 - 134133.5
  ----------------------------------------------------------------------------------------------------------------------------------------------- ------------------- ----------------------------------- --------------------- -------------------

Median ADQ per 1000 STAR-PUs for each predictor group.

RESULTS {#S7}
=======

Details of the distribution of the variables used in the multiple regression analysis are shown in [Table 1](#T1){ref-type="table"}. There was wide variation in minor tranquiliser prescribing, with a median prescribed volume of 9887.2 ADQs per 1000 STAR-PUs (Inter-Quartile Range: 6794.2 to 14132.5; range: 109.2 to 134133.5).

[Table 2](#T2){ref-type="table"} summarises the regression results. The coefficient 10β -- the inverse ('back transformation') of the logarithm -- expresses the impact that each parameter has on the 'original' practice prescribing rate, adjusting for other factors. For example, being located in a heavily deprived area (IMD\>40) increases a general practice's prescribing rate by a factor of 1.532 compared with being located in the most affluent area (IMD ≤ 10).

###### 

Multivariate associations between prescribing volume and predictor variables

  -------------------------------------------------------- ------------------- --------------------- --------------------------------------- -------------------- ------------------------- ------------------------------------------
  Predictor group                                          Category            ß coefficient         Back transformed change factor (10\_)   Prescribing change   95% Confidence interval   Back transformed 95% confidence interval
  Proportion of patients from south Asian ethnic group A   0%                  Baseline comparator                                                                                          
  Proportion of patients from south Asian ethnic group B   \>0 and \<=2%       0.017                 1.040                                   245.7                0.000 -- 0.034            1.0 -- 1.082
  Proportion of patients from south Asian ethnic group C   \>2 and \<=10%      0.039                 1.094                                   574.8                0.017 -- 0.060            1.041 -- 1.149
  Proportion of patients from south Asian ethnic group D   \>10%               -0.004                0.991                                   -52.7                -0.030 -- 0.023           0.933 -- 1.054
  Proportion of patients from black ethnic group A         0%                  Baseline comparator                                                                                          
  Proportion of patients from black ethnic group B         \>0 and \<=2%       -0.022                0.951                                   -300.4               -0.036 -- -0.008          0.921 -- 0.982
  Proportion of patients from black ethnic group C         \>2 and \<=10%      -0.115                0.767                                   -1429.7              -0.138 -- -0.093          0.728 -- 0.808
  Proportion of patients from black ethnic group D         \>10%               -0.253                0.558                                   -2707.9              -0.284 -- -0.093          0.519 -- 0.599
  Unadjusted disease prevalence: mental health A           \<=0.5%             Baseline comparator                                                                                          
  Unadjusted disease prevalence: mental health B           \> 0.5% and \<=1%   0.013                 1.031                                   191.2                0.002 - 0.025             1.004 -- 1.059
  Unadjusted disease prevalence: mental health C           \>1%                0.040                 1.095                                   583.3                0.020 -- 0.059            1.046 -- 1.147
  Unadjusted disease prevalence: epilepsy A                \<=0.5%             Baseline comparator                                                                                          
  Unadjusted disease prevalence: epilepsy B                \> 0.5% and \<=1%   0.065                 1.161                                   985.9                0.051 -- 0.078            1.126 -- 1.197
  Unadjusted disease prevalence: epilepsy C                \>1%                0.150                 1.413                                   2531.0               0.116 -- 0.184            1.307 -- 1.528
  Index of Multiple Deprivation A                          \<=10               Baseline comparator                                                                                          
  Index of Multiple Deprivation B                          \>10 and \<=20      0.044                 1.107                                   655.4                0.030 -- 0.059            1.071 -- 1.144
  Index of Multiple Deprivation C                          \>20 and \<=40      0.120                 1.319                                   1956.8               0.104 -- 0.136            1.272 -- 1.369
  Index of Multiple Deprivation D                          \>40                0.185                 1.532                                   3260.9               0.166 -- 0.205            1.466 -- 1.602
  Mean general practice GP age A                           \<40                Baseline comparator                                                                                          
  Mean general practice GP age B                           \>=40 and \<50      0.027                 1.064                                   394.0                0.008 -- 0.046            1.019 -- 1.111
  Mean general practice GP age C                           \>=50 and \<60      0.066                 1.164                                   1005.5               0.045 -- 0.088            1.108 -- 1.225
  Mean general practice GP age D                           \>=60               0.074                 1.186                                   1142.2               0.043 -- 0.105            1.105 -- 1.274
  Proportion of list aged 75 or over A                     \<=5%               Baseline comparator                                                                                          
  Proportion of list aged 75 or over B                     \>5% and \<=10%     0.071                 1.178                                   1092.0               0.054 -- 0.888            1.131 -- 1.227
  Proportion of list aged 75 or over C                     \>10%               0.092                 1.236                                   1444.5               0.070 -- 0.113            1.176 -- 1.298
  Group practice                                                               Baseline comparator                                                                                          
  Single-handed practice                                                       -0.008                0.982                                   -111.5               -0.026 -- 0.010           0.943 -- 1.022
  Non-training practice                                                        Baseline comparator                                                                                          
  Training practice                                                            -0.047                0.897                                   -631.7               -0.059 -- -0.036          0.873 -- 0.921
  Constant                                                                     3.787                 6127.13                                                      3.756 -- 3.818            5705.0 -- 6580.6
  -------------------------------------------------------- ------------------- --------------------- --------------------------------------- -------------------- ------------------------- ------------------------------------------

The coefficient of 10p for the baseline category of each categorical variable is 1. The model coefficients show that general practices located in increasingly deprived areas have increasingly higher prescribing rates for minor tranquillisers. This is also true for general practices whose GPs are, on average, older, that have an increasingly greater proportion of patients aged 75 and over, and whose patients have, independently, a greater prevalence of epilepsy and mental health problems. In contrast, practices with an increasingly greater proportion of black patients have increasingly lower prescribing rates for minor tranquillisers: however, this is not true of practices with increasing proportions of South Asian patients where prescribing rates are more constant. Training practices have lower prescribing rates than non-training practices. There is little difference between the prescribing rates of single-handed and multi-handed practices.

DISCUSSION {#S8}
==========

This study provides a national perspective on variations in minor tranquiliser prescribing by GPs, using data from a range of routinely collected datasets for 96.7% of English general practices. Previous small-scale studies have established a variety of predictive associations, often with results related and bound to the distinctive characteristics of those study areas. Using a national approach to general practice-level study does, however, encounter some potential constraints. Bias may be introduced by ascribing inaccurate small area population factors to general practices. Patients living in an area attributed to the practice may be registered at a practice elsewhere. A further limitation was the lack of availability of individual patient-level data. The study allocated area-based population characteristics to general practices on the basis of their geographical locations. Use of proxy data could possibly lead to the ecological fallacy whereby general characteristics attributed to a population group may be attributed wrongly to individuals within the group. For example, ethnic origin data in this study were aggregated from more finely distinct ethnic categories, into broader groups of South Asian, black, mixed and white, which could obscure some of the cultural and health behavioural differences within those groups. It has been argued that an ecological level study can be appropriate for between population comparisons and that small area indicators such as the IMD score are valid proxy measures for general practice populations.[@B35],[@B36]

The results from this study suggest extensive variation in minor tranquiliser prescribing by general practitioners. More minor tranquilisers were prescribed by general practices situated in areas of higher local deprivation. Higher prescribing was also associated with practices with proportionally older registered. Higher prevalence of epilepsy also predicted higher rates of minor tranquilising prescribing. Practices in areas with higher proportions of residents from black ethnic groups showed significantly negative prescribing rates. Previous research investigating a range of health conditions, revealed lower prescribing volumes in areas with higher ethnic minority populations.[@B8] The reasons for lower prescribing were not clear from the data, however, possible influences of doctor- patient relationships and the broader social context of health service bias to the wider white population were postulated. Further study may reveal whether this variation is caused by lower reported symptoms of anxiety and depression for this population group or due to unequal access to treatments.

General practices with older general practitioners were positively associated with higher minor tranquiliser prescribing. There is scope for further research concerning general practitioner demographics and approaches to appropriate minor tranquiliser prescribing. Previous qualitative research of differences in general practitioners' views and behaviour concerning medical risk and benzodiazepine prescribing, highlighted improvements in accepted practice.[@B37] However, the study showed that there was not uniform aversion to benzodiazepine prescribing, despite their unfavoured status, with differences in attitude to patient risk. Other primary care research has reported differences in antidepressant drug knowledge and prescribing behaviour between older and younger general practitioners, with older general practitioners having less confidence in treating late-life depression and being more aware of the need for further psychiatric training.[@B38],[@B39] Previous studies have investigated patient and physician barriers to recognition, diagnosis and effective treatment of depression. There is evidence of patient unwillingness to admit presence of depression, the nature of depression, along with difficulties faced by general practitioners in recognising and treating depression in culturally diverse populations.[@B40],[@B41]

Our study revealed a clear association between epilepsy and increased minor tranquiliser prescribing. Previous primary care based research found association between depression prevalence and complaints of side-effects of antiepileptic medication and with recent episodes of epileptic seizures.[@B42] The study highlighted implications for care management and reduction of depression and epileptic co-morbidity, particularly through screening for and identifying adverse reactions to antiepileptic drugs. Further work could establish whether increased care management of epilepsy might reduce prescribing for associated acute anxiety disorders.

CONCLUSIONS {#S9}
===========

The findings in this study have implications about the appropriateness of effective care for people with generalised anxiety disorders in terms of prescribing. The associated group of prescribing variation predictors indicate a complex interplay of prescribing behaviour and geographically based socio-demographic factors influencing clinical care. In light of the distinct negative associations of antidepressant prescribing and effects of patient ethnicity, further work is needed to explore reasons for these prescribing differences and related issues of prescribing management. Further study is warranted to determine the barriers to provision of appropriate minor tranquiliser prescribing amongst general practices serving larger populations of black ethnic origin.
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Minor tranquilisers are defined as those categorised by the World Health Organisation (WHO) Anatomical Therapeutic Chemical (ATC) classifications N05B: Anxiolytics; N05C: Hypnotics and Sedatives, or by the British National Formulary (BNF), Chapter 4.1: anxiolytics, hypnotics and barbiturates.
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